I-MAB American Depositary Shares

Go to I-MAB American Depositary Shares Website

$3.43

0.06 (1.78%)
Live
Previous Close

$3.37

Day Range

$0 - $0

Previous Day Range

$2.93 - $3.4

Market Cap

$239.3 million USD

Day Vol.

0

Previous Day Vol.

3.6 million

Currency

USD

Primary Exchange

Nasdaq

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of C...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

I-Mab, a biotech company, is raising $65 million through an underwritten offering of 33,333,334 American Depositary Shares at $1.95 per ADS, with proceeds intended to fund clinical development of its pipeline, particularly the givastomig drug candidate.

Related tickers: IMAB.

Read Full Article

I-Mab reported promising Phase 1b trial results for givastomig, a bispecific antibody targeting Claudin 18.2-positive gastric cancers, demonstrating an 83% objective response rate in combination with immunochemotherapy.

Related tickers: IMAB.

Read Full Article
Trending Tickers

Please sign in to view